Skip to main content
SpringerLink
Log in

Xanthine oxidase inhibitors in elderly patients with heart failure: useful or useless?

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cicero AF, Salvi P, D'Addato S, Rosticci M, Borghi C, Brisighella Heart Study g (2014) Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. J Hypertens 32(1):57–64. https://doi.org/10.1097/HJH.0b013e328365b916

    Article  CAS  PubMed  Google Scholar 

  2. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension the PIUMA study. Hypertension 36(6):1072–1078

    Article  CAS  PubMed  Google Scholar 

  3. Andrikou I, Tsioufis C, Dimitriadis K, Konstantinidis D, Kasiakogias A, Kouremeti M, Andrikou E, Karapati I, Kalos T, Fragoulis C, Liatakis I, Koutra E, Kyriazopoulos K, Thomopoulos C, Tousoulis D (2018) Uric acid as an independent predictor of coronary artery disease in essential hypertension: data from an 8-year-follow-up study. Clin Exp Pharmacol Physiol 45(8):866–869. https://doi.org/10.1111/1440-1681.12928

    Article  CAS  PubMed  Google Scholar 

  4. Larsen TR, Gerke O, Diederichsen ACP, Lambrechtsen J, Steffensen FH, Sand NP, Saaby L, Antonsen S, Mickley H (2018) The association between uric acid levels and different clinical manifestations of coronary artery disease. Coron Artery Dis 29(3):194–203. https://doi.org/10.1097/MCA.0000000000000593

    Article  PubMed  Google Scholar 

  5. Arevalo-Lorido JC, Carretero-Gomez J, Robles NR (2018) Serum uric acid levels and outcome during admission in acute ischaemic stroke, depending on renal function. Int J Neurosci 128(10):906–912. https://doi.org/10.1080/00207454.2018.1441150

    Article  CAS  PubMed  Google Scholar 

  6. Mapoure YN, Ayeah CM, Ba H, Hentchoya R, Luma HN (2018) The prognostic value of serum uric acid in the acute phase of ischemic stroke in black Africans. J Stroke Cerebrovasc Dis 27(3):783–792. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.10.006

    Article  PubMed  Google Scholar 

  7. Gu J, Fan YQ, Zhang HL, Zhang JF, Wang CQ (2018) Serum uric acid is associated with incidence of heart failure with preserved ejection fraction and cardiovascular events in patients with arterial hypertension. J Clin Hypertens 20(3):560–567. https://doi.org/10.1111/jch.13210 (Greenwich)

    Article  CAS  Google Scholar 

  8. Wannamethee SG, Papacosta O, Lennon L, Whincup PH (2018) Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: the British Regional Heart Study. Int J Cardiol 252:187–192. https://doi.org/10.1016/j.ijcard.2017.11.083

    Article  PubMed  PubMed Central  Google Scholar 

  9. von Lueder TG, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M, Pitt B, Dickstein K, Zannad F, Rossignol P, High-Risk Myocardial Infarction Database Initiative I (2015) Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the high-risk myocardial infarction database initiative. Eur J Heart Fail 17(11):1144–1151. https://doi.org/10.1002/ejhf.419

    Article  CAS  Google Scholar 

  10. Bombelli M, Quarti-Trevano F, Tadic M, Facchetti R, Cuspidi C, Mancia G, Grassi G (2018) Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study. J Hypertens 36(7):1492–1498. https://doi.org/10.1097/HJH.0000000000001721

    Article  CAS  PubMed  Google Scholar 

  11. Chen YY, Kao TW, Yang HF, Chou CW, Wu CJ, Lai CH, Sun YS, Wang CC, Chen WL (2018) The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects—an observational study. Clin Chim Acta 478:68–73. https://doi.org/10.1016/j.cca.2017.12.038

    Article  CAS  PubMed  Google Scholar 

  12. Nakagawa T, Cirillo P, Sato W, Gersch M, Sautin Y, Roncal C, Mu W, Sanchez-Lozada LG, Johnson RJ (2008) The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med 3(4):313–318. https://doi.org/10.1007/s11739-008-0141-3

    Article  PubMed  PubMed Central  Google Scholar 

  13. Beattie CJ, Fulton RL, Higgins P, Padmanabhan S, McCallum L, Walters MR, Dominiczak AF, Touyz RM, Dawson J (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension 64(5):1102–1107. https://doi.org/10.1161/HYPERTENSIONAHA.114.03953

    Article  CAS  PubMed  Google Scholar 

  14. Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300(8):924–932. https://doi.org/10.1001/jama.300.8.924

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lin HC, Daimon M, Wang CH, Ho Y, Uang YS, Chiang SJ, Wang LH (2017) Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: a population-based study. Int J Cardiol 233:85–90. https://doi.org/10.1016/j.ijcard.2017.02.013

    Article  PubMed  Google Scholar 

  16. Hays AG, Iantorno M, Schar M, Lai S, Czarny M, Breton E, Palmer RN, Whelton A, Weiss RG, Gerstenblith G (2018) The influence of febuxostat on coronary artery endothelial dysfunction in patients with coronary artery disease: a phase 4 randomized, placebo-controlled, double-blind, crossover trial. Am Heart J 197:85–93. https://doi.org/10.1016/j.ahj.2017.11.006

    Article  CAS  PubMed  Google Scholar 

  17. Grassi D, Pontremoli R, Bocale R, Ferri C, Desideri G (2014) Therapeutic approaches to chronic hyperuricemia and gout. High Blood Press Cardiovasc Prev 21(4):243–250. https://doi.org/10.1007/s40292-014-0051-6

    Article  CAS  PubMed  Google Scholar 

  18. Grassi D, Desideri G, Di Giacomantonio AV, Di Giosia P, Ferri C (2014) Hyperuricemia and cardiovascular risk. High Blood Press Cardiovasc Prev 21(4):235–242. https://doi.org/10.1007/s40292-014-0046-3

    Article  CAS  PubMed  Google Scholar 

  19. Hare JM, Mangal B, Brown J, Fisher C, Freudenberger R, Colucci WS, Mann DL, Liu P, Givertz MM, Schwarz RP, Investigators O-C (2008) Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 51(24):2301–2309. https://doi.org/10.1016/j.jacc.2008.01.068

    Article  CAS  PubMed  Google Scholar 

  20. Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, Margulies KB, Cappola TP, Konstam MA, Semigran MJ, McNulty SE, Lee KL, Shah MR, Hernandez AF, Network NHFCR (2015) Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study. Circulation 131(20):1763–1771. https://doi.org/10.1161/CIRCULATIONAHA.114.014536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Xiao J, Deng SB, She Q, Li J, Kao GY, Wang JS, Ma Y (2016) Allopurinol ameliorates cardiac function in non-hyperuricaemic patients with chronic heart failure. Eur Rev Med Pharmacol Sci 20(4):756–761

    CAS  PubMed  Google Scholar 

  22. Cicero AF, Rosticci M, Parini A, Baronio C, D'Addato S, Borghi C (2014) Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study. Intern Emerg Med 9(6):655–660. https://doi.org/10.1007/s11739-013-1016-9

    Article  PubMed  Google Scholar 

  23. Cicero AFG, Cosentino ER, Kuwabara M, Esposti DD, Borghi C (2019) Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02070-y

    Article  PubMed  Google Scholar 

  24. White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L, Investigators C (2018) Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med 378(13):1200–1210. https://doi.org/10.1056/NEJMoa1710895

    Article  CAS  PubMed  Google Scholar 

  25. Desideri G, Virdis A, Casiglia E, Borghi C, Working Group on Uric A, Cardiovascular Risk of the Italian Society of H (2018) Exploration into uric and cardiovascular disease: uric acid right for heart health (URRAH) project, a study protocol for a retrospective observational study. High Blood Press Cardiovasc Prev 25(2):197–202. https://doi.org/10.1007/s40292-018-0250-7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hypertension Unit, Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant’Andrea Hospital, Rome, Italy

    Vivianne Presta, Barbara Citoni & Giuliano Tocci

  2. IRCCS Neuromed, Pozzilli, IS, Italy

    Giuliano Tocci

Authors
  1. Vivianne Presta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Citoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuliano Tocci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuliano Tocci.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statements on human and animal rights

This article does not contain data derived by any current studies with human participants performed by any of the authors. The clinical studies mentioned were provided with specific ethical approval.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Commentary on the manuscript entitled Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Presta, V., Citoni, B. & Tocci, G. Xanthine oxidase inhibitors in elderly patients with heart failure: useful or useless?. Intern Emerg Med 14, 903–905 (2019). https://doi.org/10.1007/s11739-019-02105-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-019-02105-4

Search

Navigation